Subscribe To
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023
— Fourth Quarter and Full Year Revenue of $39.8 Million and $149.3 Million, Respectively, Both Represent a Record-High Achievement — — Signed $55 Million in Net New Business Orders Resulting in a Record-High Backlog of $191 Million — — Mammalian Cell Manufacturing and Process Development Facility Expansions Currently Online and Active, Adding Approximately $120 Million […] The post Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023 appeared first o...
Read More
Posted: Jun 21 2023, 20:07
Author Name: forextv
Views: 081176